SINA [SINA] SC 13D/A: SHARE SUBSCRIPTION AGREEMENT Agreement Company Subscriber This Share

[SHARE SUBSCRIPTION AGREEMENT Agreement Company Subscriber This Share Subscription Agreement (this “ Party, Parties The Subscriber and the Company are each referred to herein as a “ W I T N E S S E T H WHEREAS Class A Preference Shares Securities Act NOW, THEREFORE ARTICLE I SUBSCRIPTION OF CLASS A P]

By | 2017-11-16T03:08:47+00:00 November 15th, 2017|Categories: Chinese Stocks, SINA, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: FORM 10-Q (Mark One) ☒ June 30, 2017

[FORM 10-Q (Mark One) ☒ June 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number)]

By | 2017-11-16T03:06:24+00:00 November 15th, 2017|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

JASO [JA Solar] 6-K: (Original Filing)

[JA Solar Announces Third Quarter 201 7 Results BEIJING, Third Quarter 201 7 Highlights · Total shipments were 1,640.9 megawatts (“ MW ”) , consisting of 1,582.5 MW of modules and 37.9 MW of cells to external customers, and 20.5 MW of modules to the Company’s downstream projects . External shipments ]

By | 2017-11-16T03:07:02+00:00 November 15th, 2017|Categories: Chinese Stocks, JASO, SEC Original|Tags: , , , , , |0 Comments

SINA [SINA] SC 13D/A: (Original Filing)

[SHARE SUBSCRIPTION AGREEMENT Agreement Company Subscriber This Share Subscription Agreement (this “ Party, Parties The Subscriber and the Company are each referred to herein as a “ W I T N E S S E T H WHEREAS Class A Preference Shares Securities Act NOW, THEREFORE ARTICLE I SUBSCRIPTION OF CLASS A P]

By | 2017-11-16T03:08:43+00:00 November 15th, 2017|Categories: Chinese Stocks, SEC Original, SINA|Tags: , , , , , |0 Comments

JD [JD.com] 6-K: (Original Filing)

[JD.com Announces Third Quarter 2017 Results Beijing, China Third Quarter 2017 Highlights for Continuing Operations · Net revenues 1 2 · Gross profit 3 Non-GAAP gross profit 4 · Net income from continuing operations attributable to ordinary shareholders Non-GAAP net income from continuing operations ]

By | 2017-11-16T03:08:03+00:00 November 15th, 2017|Categories: Chinese Stocks, JD, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) ☒ June 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number)]

By | 2017-11-16T03:06:21+00:00 November 15th, 2017|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar